Cambridge Investment Research Advisors, Inc. Corcept Therapeutics Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 19,766 shares of CORT stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,766
Previous 26,855
26.4%
Holding current value
$1.16 Million
Previous $1.24 Million
19.87%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CORT
# of Institutions
403Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$970 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$593 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$475 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$364 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$225 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.28B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...